Relevant bibliographies by topics / Diagnosis and monitoring of bladder cancer / Books
To see the other types of publications on this topic, follow the link: Diagnosis and monitoring of bladder cancer.

Books on the topic 'Diagnosis and monitoring of bladder cancer'

Author: Grafiati
Published: 29 March 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Diagnosis and monitoring of bladder cancer.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

J, Droller Michael, ed. Bladder cancer: Current diagnosis and treatment. Totowa, N.J: Humana Press, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Nilsson, William E. Bladder cancer: Etymology, diagnosis, and treatments. Hauppauge, N.Y: Nova Science Publishers, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lee, Cheryl T. Bladder cancer: Diagnosis, therapeutics, and management. New York, NY: Humana Press, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

N, Syrigos Konstantinos, and Skinner Donald G, eds. Bladder cancer: Biology, diagnosis, and management. Oxford: Oxford University Press, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

A, Stoll Basil, ed. Screening and monitoring of cancer. Chichester: Wiley, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hayat, M. A. Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine Cancer, Skin Cancer, Leukemia, Multiple Myeloma and Sarcoma. Dordrecht: Springer Science+Business Media B.V., 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

G, Maldonado Jonathon, and Cervantes Mikayla K, eds. Small cell carcinomas: Causes, diagnosis and treatment. Hauppauge, N.Y: Nova Science, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Maldonado, Jonathon G. Small cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Galsky, Matthew D. Dx/Rx: Genitourinary oncology : cancer of the kidneys, bladders, and testis. 2nd ed. Sudbury, Mass: Jones & Bartlett Learning, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Giampietro, Gasparini, and Hayes Daniel 1951-, eds. Biomarkers in breast cancer: Molecular diagnostics for predicting and monitoring therapeutic effect. Totowa, N.J: Humana Press, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Maldonado, Jonathon G., and Mikayla K. Cervantes. Small cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Canada. Health Canada. Evaluation Indicators Working Group. Guidelines for monitoring breast screening program performance: Report from the Evaluation Indicators Working Group. 2nd ed. [Ottawa]: Public Health Agency of Canada, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Australian Institute of Health and Welfare. National Bowel Cancer Screening Program monitoring report, 2008: 7 August 2006-30 June 2008. Canberra: Australian Institute of Health and Welfare, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Barentsz, Jelle O. Magnetic resonance imaging of carcinoma of the urinary bladder. Dordrecht: Kluwer Academic Publishers, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Australia, BreastScreen. BreastScreen Australia monitoring report / the Australian Institute of Health Welfare and the Australian Government Department of Health and Aging for the BreastScreen Australia Program. Canberra: Australian Institute of Health and Welfare, c2003., 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Group, Canada Health Canada Evaluation Indicators Working. Report from the Evaluation Indicators Working Group: Guidelines for monitoring breast screening program performance. [Ottawa]: Health Canada, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Canada. Health Canada. Evaluation Indicators Working Group. Report from the Evaluation Indicators Working Group: Guidelines for monitoring breast screening program performance. 2nd ed. [Ottawa]: Public Health Agency of Canada, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

E, Matouschek, European Organization for Research on Treatment of Cancer. Genito-Urinary Tract Cancer Cooperative Group., and World Health Organization. Collaborating Centre for Urinary Bladder and Prostatic Cancer, eds. Endourology: [proceedings of the Third Congress of the International Society of Urologic Endoscopy, together with World Health Organization (W.H.O.) Collaborating Centre for Urinary Bladder and Prostatic Cancer and with European Organization of Research on the Treatment of Cancer (E.O.R.T.C.) Genito-Urinary Tract Cancer Cooperative Group; August 26-30, 1984, Karlsruhe, Federal Republic of Germany]. Baden-Baden: BuA-Verlag Werner Steinbrück, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Public Health Agency of Canada. Centre for Chronic Disease Prevention and Control and Agence de santé publique du Canada. Centre de prévention et de contrôle des maladies chroniques, eds. Report from the evaluation indicators working group: Guidelines for monitoring breast screening program performance = Rapport du groupe de travail sur les indicateurs d'évaluation : lignes directrices pour la surveillance de la performance des programmes de dépistage du cancer du sein. 2nd ed. [Ottawa, Ont.]: Public Health Agency of Canada = Agence de santé publique du Canada, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Lee, Cheryl T., and David P. Wood. Bladder Cancer. Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Syrigos, Konstantinos, and Konstantinos N. Syrigos. Bladder Cancer: Biology, Diagnosis, Management. John Wiley & Sons Inc, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Bladder Cancer: Diagnosis and Clinical Management. Wiley-Interscience, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Bladder Cancer: Current Diagnosis and Treatment. Humana Press, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Schoenberg, Mark P., Seth P. Lerner, and Cora N. Sternberg. Bladder Cancer: Diagnosis and Clinical Management. Wiley & Sons, Incorporated, John, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Droller, MD Michael J. Bladder Cancer: Current Diagnosis and Treatment. Humana, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Schoenberg, Mark P., Seth P. Lerner, and Cora N. Sternberg. Bladder Cancer: Diagnosis and Clinical Management. Wiley & Sons, Incorporated, John, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Lee, Cheryl T., and David P. Wood. Bladder Cancer: Diagnosis, Therapeutics, and Management. Humana Press, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

Schoenberg, Mark P., Seth P. Lerner, and Cora N. Sternberg. Bladder Cancer: Diagnosis and Clinical Management. Wiley & Sons, Limited, John, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Silverman, Debra T., Stella Koutros, Jonine D. Figueroa, Ludmila Prokunina-Olsson, and Nathaniel Rothman. Bladder Cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0052.

Full text
Abstract:
In the United States, an estimated 74,000 new cases of bladder cancer and 16,000 deaths occur annually. Because of favorable survival, approximately 578,000 persons are alive after diagnosis. Recurrence after treatment is common, necessitating lifelong surveillance and care, making bladder cancer the most costly malignancy from diagnosis to death. The median age at diagnosis has increased from 67 years in 1980 to 73 years in 2008–2012. Incidence rates rise dramatically with age, suggesting that as the US population ages, the burden of bladder cancer in the United States will continue to grow. Worldwide over 1.3 million cases are estimated to occur annually. Cigarette smoking is the principal known cause of bladder cancer, along with various chemical exposures. Recent studies suggest that, over the past two decades, the risk for current smokers has increased from three times the risk of nonsmokers to about four to five times the nonsmoker risk.
APA, Harvard, Vancouver, ISO, and other styles
30

(Editor), Konstantinos N. Syrigos, and Donald Skinner (Editor), eds. Bladder Cancer: Biology, Diagnosis and Management (Oxford Medical Publications). Oxford University Press, USA, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Teoh, Jeremy, and Daniele Castellani, eds. Recent Advances in Bladder Cancer Diagnosis and Treatment. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-080-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Droller, Michael J. Bladder Cancer: Current Diagnosis and Treatment (Current Clinical Urology). Humana Press, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

Ziglioli, Francesco, and Umberto Maestroni. Modern Approach to Diagnosis and Treatment of Bladder Cancer. IntechOpen, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Bladder Cancer: Diagnosis, Therapeutics, and Management (Current Clinical Urology). Humana Press, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Bellmunt, Joaquim. Bladder Cancer, an Issue of Hematology/Oncology Clinics of North America. Elsevier, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

Chapman, Hannah, and Christine Elwell. Renal and bladder cancer. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0167.

Full text
Abstract:
This chapter addresses the diagnosis and management of bladder and renal cancers. In the UK, bladder cancer is the fourth most common cancer in men, and the eighth most common cancer in women. Bladder cancer arises from the bladder urothelium, and is typically a papillary transitional cell carcinoma. Chronic infection with the parasite Schistosoma haematobium is associated with squamous cell carcinoma of the bladder, and is most prevalent in Egypt and sub-Saharan Africa. Renal cancer accounts for 3% of cancers in adults in the UK and, in most cases, is a renal cell carcinoma arising from proximal renal tubule epithelium. A further 5%–10% of renal cancers are transitional cell (urothelial) carcinomas of the renal pelvis. Benign kidney tumours, such as cysts, are also common.
APA, Harvard, Vancouver, ISO, and other styles
37

Brinkman, Maree, and Maurice Zeegars. Screening for bladder cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0073.

Full text
Abstract:
Bladder cancer (BC) is one of the most common urological malignancies and ranks ninth among all cancers worldwide. While screening has the potential to detect early cases of BC and reduce disease specific mortality, to date there are no routine screening programmes of asymptomatic individuals conducted anywhere in the world. There are however, a range of tests and procedures available for the detection and subsequent diagnosis of BC for select individuals presenting with urological symptoms and who are at increased risk of the disease.This chapter provides an overview of the traditional screening tools used for the detection of BC, such as urinalysis for haematuria and urinary cytology, as well as a brief description of follow-up procedures including cystoscopy, imaging, and treatment modalities.
APA, Harvard, Vancouver, ISO, and other styles
38

Bryant, Richard J., and James W. F. Catto. General overview of bladder cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0074.

Full text
Abstract:
Bladder cancer (BC) is a common malignancy and is one of the most expensive to manage. This tumour typically affects middle-aged and elderly patients and is more common in men. These demographics reflect the aetiological links between BC and tobacco smoking and occupational exposure to carcinogens. While the presenting symptom of BC is usually painless visible haematuria, around one-quarter of tumours present with irritative voiding symptoms, recurrent or antibiotic-refractory urinary tract infections, non-visible haematuria, or are found by chance during the investigation of unrelated symptoms. As such, these urological symptoms require urgent investigation in patients at risk of BC. The diagnosis of BC is confirmed by endoscopic transurethral resection. This procedure requires meticulous tumour excision, sampling of the underlying detrusor muscle and the flat urothelium or prostatic urethra in patients with high-grade cancers. The prognosis of BC depends upon tumour grade, stage, and other features.
APA, Harvard, Vancouver, ISO, and other styles
39

Small cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
40

Goossens, Maria E., Frank Buntinx, and Maurice P. Zeegers. Bladder and upper urinary tract cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0070.

Full text
Abstract:
Urinary bladder cancer (UBC) ranks ninth in worldwide cancer incidence. The most common histological type in Western countries is transitional cell carcinoma (TCC), while in Africa, a substantial proportion of squamous cell carcinomas (SCC) are observed related to the prevalence of infection with Schistosoma haematobium (bilharziasis). UBC has the highest per-patient lifetime cost for cancer in terms of healthcare expenditure compared to all other types of cancer. It is more frequent in men than in women and age is now widely accepted as the greatest single risk factor for developing UBC. The median age at diagnosis is 70 years. Cigarette smoking and specific occupational exposures, such as carcinogenic dyes for painters, are the main known causes of UBC.
APA, Harvard, Vancouver, ISO, and other styles
41

Hayat, M. A. Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine ... Leukemia, Multiple Myeloma and Sarcoma. Springer, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
42

Luo, Yongwen, Yi Zhang, Yu Xiao, and Fang-Ming Deng, eds. Molecular Biomarkers and Imaging Markers in the Prediction, Diagnosis, and Prognosis of Bladder Cancer. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-629-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Ma, Chao, Rong Fan, and Antoni Ribas, eds. Cancer Immunotherapy & Immuno-monitoring: Mechanism, Treatment, Diagnosis, and Emerging Tools. Frontiers SA Media, 2014. http://dx.doi.org/10.3389/978-2-88919-380-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Persad, Raj, ed. Advances in the Scientific Evaluation of Bladder Cancer and Molecular Basis for Diagnosis and Treatment. InTech, 2013. http://dx.doi.org/10.5772/56665.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Biomarkers in breast cancer: Molecular diagnostics for predicting and monitoring therapeutic effect. Totowa, N.J: Humana Press, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
46

Breit, Alfred, P. Lukas, and A. Heuck. Tumor Response Monitoring and Treatment Planning: Advanced Radiation Therapy. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
47

Breit, Alfred. Tumor Response Monitoring and Treatment Planning: Advanced Radiation Therapy. Springer-Verlag Telos, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
48

Breit, Alfred, P. Lukas, A. Heuck, P. Kneschaurek, and M. Mayr. Tumor Response Monitoring and Treatment Planning: Advanced Radiation Therapy. Springer London, Limited, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
49

Diagnosis, Evaluation, and Treatment of Non-Muscle Invasive Bladder Cancer: An Update, an Issue of Urologic Clinics. Elsevier - Health Sciences Division, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
50

National Bowel Cancer Screening Program monitoring report, 2008: 7 August 2006-30 June 2008. Canberra: Australian Institute of Health and Welfare, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Diagnosis and monitoring of bladder cancer' for other source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography